Accenture Plc’s CEO Pierre Nanterme is stepping down due to health reasons, the consulting company stated. Meanwhile, CFO David Rowland has been appointed as interim global leader.
Nanterme, who took over as the CEO in January 2011, was diagnosed with colon cancer in 2016.
Nanterme stated, “It has been my honour and privilege to serve Accenture’s people and our clients for my entire 36-year career, and I’ve never been more confident in our business strategy, leadership team and people. I know that David’s significant involvement in developing and delivering our growth strategy to rotate our business to new, high-growth areas of digital, cloud and security - and his tenure as a highly respected senior leader and developer of talent - will make this transition seamless.”
He added that this is the right decision for his family and himself so he can focus on his health.
Post the announcement, Accenture also named lead independent director Marge Magner as the company’s non-executive chair of the board.
Meanwhile, Rowland will be replaced by KC McClure as the CFO. He is currently heading Accenture's finance operations.
Rowland said, “I look forward to working closely with our talented, best-in-class leadership team, including KC as our new CFO, to continue building on the strong momentum in our business and strengthening our market leadership in the New.”
The company said there would be no change to its business outlook for the second quarter and full fiscal year 2019. With changes at the top just as the company steps into the New Year, the impact on the business outlook, if any, will become clear only later in the year.
Image Credits: Accenture